Evidence map›Paper›PMID 42775170›Full record

ArticleJCEM case reports2026

Pregnancy-unmasked latent autoimmune arginine vasopressin deficiency with anti-rabphilin-3a antibody positivity.

Satoshi Yamagata, Mio Naito, Seishi Furukawa, Yoshihisa Sugimura, Seiichiro Higuchi

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Satoshi YamagataDepartment of Diabetes, Endocrinology and Metabolism, Kawakita General Hospital, Tokyo 166-8588, Japan.ORCID https://orcid.org/0009-0002-2837-7355
Mio NaitoDepartment of Obstetrics and Gynecology, Kawakita General Hospital, Tokyo 166-8588, Japan.ORCID https://orcid.org/0000-0001-8750-7047
Seishi FurukawaDepartment of Obstetrics and Gynecology, Kawakita General Hospital, Tokyo 166-8588, Japan.
Yoshihisa SugimuraDepartment of Endocrinology, Diabetes and Metabolism, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.ORCID https://orcid.org/0009-0008-8702-2283
Seiichiro HiguchiDepartment of Diabetes, Endocrinology and Metabolism, Kawakita General Hospital, Tokyo 166-8588, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although pregnancy-associated arginine vasopressin (AVP) disorder is rare, it is often attributed to excessive placental vasopressinase activity. However, vasopressinase-independent mechanisms, including gestational unmasking of latent AVP deficiency (AVP-D), may occur. We report a 37-year-old primigravid female who developed severe polydipsia and polyuria in the third trimester. She had hypotonic polyuria with inappropriately low plasma AVP levels and loss of the posterior pituitary bright spot on T1-weighted magnetic resonance imaging (MRI). AVP-D was suspected; desmopressin promptly relieved her symptoms. Desmopressin became unnecessary immediately following delivery; however, at 6 months postpartum, her polydipsia and polyuria recurred. Anterior pituitary dysfunction subsequently developed. Notably, at 6 months postpartum, the posterior pituitary bright spot on MRI remained absent. Herein, the transient postpartum improvement initially mimicked gestational AVP disorder; however, retrospective testing revealed anti-rabphilin-3A antibody positivity, indicating autoimmune hypophysitis involvement. Persistent MRI abnormalities, postdelivery AVP-D recurrence, and subsequent anterior pituitary dysfunction supported an underlying autoimmune etiology. This case raises the possibility that pregnancy may unmask latent autoimmune AVP-D through a vasopressinase-independent mechanism. In patients who develop AVP-D during pregnancy, anti-rabphilin-3A antibody positivity and persistent loss of the posterior pituitary bright spot on MRI may offer crucial diagnostic clues, supporting the significance of long-term endocrine follow-up.

Indexed as

anti-rabphilin-3A antibodyarginine vasopressin deficiencypregnancy

Identifiers

PMID42775170
PMCPMC13595274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.